GB0112342D0 - Polypeptides - Google Patents
PolypeptidesInfo
- Publication number
- GB0112342D0 GB0112342D0 GBGB0112342.1A GB0112342A GB0112342D0 GB 0112342 D0 GB0112342 D0 GB 0112342D0 GB 0112342 A GB0112342 A GB 0112342A GB 0112342 D0 GB0112342 D0 GB 0112342D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- polypeptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
- A61K40/4244—Enzymes
- A61K40/4246—Telomerase or [telomerase reverse transcriptase [TERT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0112342.1A GB0112342D0 (en) | 2001-05-21 | 2001-05-21 | Polypeptides |
PCT/NO2002/000176 WO2002094312A1 (en) | 2001-05-21 | 2002-05-16 | Polypeptides derived from human telomerase reverse transcriptase |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0112342.1A GB0112342D0 (en) | 2001-05-21 | 2001-05-21 | Polypeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0112342D0 true GB0112342D0 (en) | 2001-07-11 |
Family
ID=9915009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0112342.1A Ceased GB0112342D0 (en) | 2001-05-21 | 2001-05-21 | Polypeptides |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0112342D0 (en) |
WO (1) | WO2002094312A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1601684B1 (en) * | 2003-03-05 | 2014-10-15 | Dendreon Corporation | Alternative reading frame polypeptides for treatment |
GB0821616D0 (en) | 2008-11-26 | 2008-12-31 | Lytix Biopharma As | Compounds |
LT2536830T (en) | 2010-02-16 | 2019-11-11 | Ultimovacs Asa | POLYPEPTIDIDES |
EP2636752A1 (en) * | 2012-03-06 | 2013-09-11 | Universiteit Maastricht | In vitro method for determining disease outcome in pulmonary carcinoids. |
CN104768967B (en) * | 2012-09-19 | 2019-02-15 | 珍白斯凯尔有限公司 | Cell-penetrating peptides, conjugates comprising the peptides, and compositions comprising the conjugates |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1291231B (en) * | 1996-10-01 | 2010-06-02 | 杰龙公司 | human telomerase catalytic subunit |
JP2002514928A (en) * | 1997-07-01 | 2002-05-21 | キャンビア バイオシステムス リミティド ライアビリティー カンパニー | Vertebrate telomerase genes and proteins and uses thereof |
US7030211B1 (en) * | 1998-07-08 | 2006-04-18 | Gemvax As | Antigenic peptides derived from telomerase |
-
2001
- 2001-05-21 GB GBGB0112342.1A patent/GB0112342D0/en not_active Ceased
-
2002
- 2002-05-16 WO PCT/NO2002/000176 patent/WO2002094312A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002094312A1 (en) | 2002-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0130557D0 (en) | Proteins | |
GB0130720D0 (en) | Proteins | |
GB0100196D0 (en) | Peptides | |
EP1412499A4 (en) | Cytokine polypeptides | |
AU2002359464A8 (en) | Angiopioetin related factors | |
AU2002241899A1 (en) | Tip39 polypeptides | |
GB0112342D0 (en) | Polypeptides | |
GB0109438D0 (en) | Peptides | |
GB0103517D0 (en) | Polypeptide | |
GB0018307D0 (en) | Polypeptides | |
GB0125636D0 (en) | Oligomeric polypeptides | |
EP1373306A4 (en) | Cytoskeletion-associated proteins | |
GB0105063D0 (en) | Polypeptides | |
GB0113257D0 (en) | Polypeptides | |
GB0101739D0 (en) | Novel polypeptide | |
GB0130560D0 (en) | Proteins | |
AU2002326909A8 (en) | Neurotransmission-associated proteins | |
GB0108218D0 (en) | New polypeptide | |
GB0021685D0 (en) | Polypeptides | |
GB0018908D0 (en) | Polypeptides | |
GB0008945D0 (en) | Polypeptides | |
GB0111031D0 (en) | Novel polypeptide | |
GB0107394D0 (en) | Novel polypeptide | |
GB0104118D0 (en) | Novel polypeptide | |
GB0101222D0 (en) | Novel polypeptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
COOA | Change in applicant's name or ownership of the application | ||
AT | Applications terminated before publication under section 16(1) |